Ignite Creation Date:
2025-12-26 @ 11:45 AM
Ignite Modification Date:
2026-01-29 @ 10:26 AM
Study NCT ID:
NCT00090116
Status:
COMPLETED
Last Update Posted:
2012-03-05
First Post:
2004-08-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease
Sponsor:
Forest Laboratories
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NER-MD-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None